As of 2025-06-30, the Fair Value of Amneal Pharmaceuticals Inc (AMRX) is -0.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.09 USD, the upside of Amneal Pharmaceuticals Inc is -102.57%.
With the market price of 8.09 USD and our fair value calculation, Amneal Pharmaceuticals Inc (AMRX) is not a good investment. Investing in Amneal stocks now will result in a potential loss of 102.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 91.10 | 10.62 | -129.99 | -83.99 | -116.89 | -45.83 |
| YoY growth | 125.17% | -88.34% | -1,323.51% | 35.38% | -39.16% | -258.09% |
| Market Cap (mil) | 2,535.57 |
| P/E | |
| Forward P/E |
| EPS | -0.04 |
| Avg earnings growth rate | -258.09% |
| TTM earnings | -13.05 |